Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global digital biomanufacturing market was valued at USD 2.23 Billion in 2025, driven by the rising adoption of advanced technologies like AI and machine learning across the globe. The market is anticipated to grow at a CAGR of 17.90% during the forecast period of 2026-2035, with the values likely to reach USD 11.57 Billion by 2035.
Geopolitical Impact of Iran, US, and Israel War on the Digital Biomanufacturing Market
United States: The Digital Biomanufacturing Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. IDC revised U.S. IT spending growth from 12.4% to 11.4% for 2026, with similar revisions across other markets as corporate CFOs apply caution in an inflationary, uncertain macroeconomic environment. Microsoft Azure and AWS reported investigating latency spikes at Middle Eastern data center nodes following missile strikes on Dubai and Doha infrastructure. Semiconductor and electronics supply chains routed through the Gulf region are experiencing disruption, with some production inputs stranded aboard ships unable to transit the Strait of Hormuz. IDC revised U.S. IT spending growth from 12.4% to 11.4% for 2026, reflecting corporate caution in an inflationary environment. Despite overall caution, AI-driven infrastructure investment continues to provide structural demand support. Despite spending caution, AI infrastructure investment continues to grow, with the current crisis reinforcing the case for advanced technology adoption to offset rising labor and materials costs.
Iran: Iran's domestic Digital Biomanufacturing sector has been effectively suspended by the conflict. US-Israeli strikes on industrial and civilian infrastructure across Tehran, Mashhad, Isfahan, and other major cities have disrupted all commercial activity. Power outages from attacks on electricity generation facilities have halted manufacturing operations, and the collapse of the commercial banking and logistics system has eliminated any residual trade flows. The broader humanitarian crisis, with over 1,900 casualties and 4,000+ civilian buildings damaged, has redirected the entire Iranian economy toward survival rather than production or consumption.
Israel: Israel's technology sector, a globally significant innovation hub for cybersecurity, semiconductors, AI, and various specialized verticals, is experiencing operational disruption as engineering teams are reduced by military reservist call-ups. Several Israeli companies supply components, software, and services to global Digital Biomanufacturing market participants. Business development activities have been suspended, and some operational timelines extended. However, Israel's proven resilience through previous conflict periods, and the continued operation of critical R&D programmes, suggests the disruption will be temporary rather than structural.
Government
Market
Procurement
The global market for digital manufacturing is driven by the increasing demand for biologics, biosimilars, and advanced therapies such as gene therapies and monoclonal antibodies, which require efficient digital manufacturing processes.
One of the major market trends in the digital biomanufacturing market is the rising adoption of automation and artificial intelligence for process optimization.
The leading market players are focused on improving biomanufacturing efficiency by integrating cutting-edge automation, digital analytics, and process control solutions technologies, which are likely to elevate the market value in the forecast period.
Digital biomanufacturing integrates the application of automation, artificial intelligence, the Internet of Things, and data analytics into biological production. It helps in process control, reduction in cost, improvement in quality, and scalability, which aids in the efficient and sustainable production of biopharmaceuticals and other biologics. The market is growing significantly owing to the rising adoption of biological production processes integrating these technologies. The market focuses on improving manufacturing efficiency, accuracy, and scalability in the production of biopharmaceuticals, vaccines, and other biologics.
Rising adoption of Advanced Technologies to Boost the Market Demand
The adoption of advanced technologies like AI, machine learning, and digital twins is driving the market growth. These technologies improve process optimization, increase accuracy, and enhance efficiency in drug production. For instance, in November 2024, Samsung Biologics deployed digital-twin technology and real-time monitoring systems to enhance production outputs, forecasts, and decisions. Such digital solutions ensure better precision, transparency, and cost-effectiveness, which promote market growth.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Segmentation Based on Type to Witness Substantial Growth
Based on the type, the market is divided into manufacturing technologies, analytical and process control technologies, and others. Manufacturing technologies hold a significant market share. These technologies include automation, robotics, and AI-driven solutions that can optimize production in terms of efficiency. Adoption of these technologies is required to meet the growing demand for biopharmaceuticals and vaccines. It also guarantees scalability, cost-cutting, and precision.
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is experiencing strong growth in the market, driven by substantial investment in healthcare. Innovative technologies are preceding the rise in adoption and digital manufacturing tools. The growth in Europe is due to the rising focus on sustainability, compliance with regulations, and a highly skilled workforce.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Aspen Technology specializes in asset management software. It was established in 1981 and has its headquarters in Bedford, Massachusetts. It is a global leader in the digital biomanufacturing market. Their product portfolio includes Industrial AI, plant digitalization, digital twin technology, and predictive analytics to sustain sustainability and advanced manufacturing in pharma and asset-intensive areas.
ID Business Solutions is a leading player in the global digital biomanufacturing market headquartered in Woking, UK. It specializes in digital solutions for the biopharma industry, providing products to manage data and workflow through research, bioanalysis, cell line development, and manufacturing.
Mettler Toledo was founded in 1945 and has its headquarters based in Greifensee, Switzerland. The global leader in precision instruments also offers solutions for digital biomanufacturing, which consists of laboratory balances, automated reactors, liquid handling equipment, and process analytics systems to support manufacturing processes in industries such as pharmaceuticals and biotechnology.
Dassault Systèmes was established in 1981 as an innovator in digital biomanufacturing. The company is headquartered in Vélizy-Villacoublay, France. It has flagship solutions that are being implemented to create digital twins of production to enhance the manufacturing process, improve quality, and ensure sustainability in pharmaceuticals. Products comprise the BIOVIA, DELMIA, and 3DEXPERIENCE platforms for supporting the simulation of processes, optimization of these, and end-to-end manufacturing integration.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include GE Healthcare, Siemens Healthineers AG, Schneider Electric SE, Danaher Cooperation, Getinge (Applikon Biotechnology BV), FUJIFILM Diosynth Biotechnologies Inc., SIA Bioreactors.net, Körber Digital GmbH, and Sartorius AG.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.